Retraction

Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway

Retraction Details

Retraction Reason:

Results Not Reproducible

Nature of Retraction:

Retraction

Retraction Notice:
10.1021/acsnano.0c08653
Additional Notes:

see also: https://pubpeer.com/publications/6AB70F25CC4B63B12127A16DA625BB;

Citations (216)

216
Total Citations
94
Post-Retraction
(43.5%)
121
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
3 Within 30 days
46 Within 1 year
23 After 2+ years
1384 Days since retraction (latest)
Paper citing Breast Cancer Chemo-immunotherapy through Liposoma...
Unknown Authors
Unknown Journal
Published: Unknown
Simultaneous Reversal of T Lymphocytes and Cancer Cells Metabolism Via a Biomimetic Heavy‐Atom‐Free Photosensitizers‐Based Combination Therapies to Boost Cancer Photoimmunotherapy
Yongjian Zhang, Xiaohong Wu, Kaiyuan Wang et al. (9 authors)
Advanced Science Open Access
Published: Mar 2025
2 citations
1384 days after retraction
Harnessing sulfur-doped carbon nanodots conjugated with IDO inhibitors act as a dual-mode breast cancer immunotherapy
Roberta Cillari, Rita C. Acúrcio, Andreia Barateiro et al. (6 authors)
Journal of Controlled Release
Published: Feb 2025
2 citations
1352 days after retraction
Transforming Cancer Immunotherapy: Overcoming Immunosuppression in Tumors via Gene Silencing Techniques Based on Nanoparticles
Prerona Saha, Md.Ashrarul Hasib, Babette Halder et al. (5 authors)
Journal of Drug Delivery Science and Technology
Published: Dec 2024
1 citation
1318 days after retraction
Ultrabright near-infrared fluorescent DNA frameworks for near-single-cell cancer imaging
Xia Liu, Ben Shi, Yue Gao et al. (15 authors)
Nature Photonics
Published: Oct 2024
18 citations
1239 days after retraction
Cold exposure therapy combined with bionic type I aggregation-induced emission photosensitizer for enhanced immunotherapy of breast cancer
Zhongxian Chen, Zeming Liu, Yingguang Zhou et al. (8 authors)
Materials Today Bio Open Access
Published: Aug 2024
14 citations
1191 days after retraction
Nanomaterials: leading immunogenic cell death-based cancer therapies
Changyu Ma, Zhe Cheng, Haotian Tan et al. (7 authors)
Frontiers in Immunology Open Access
Published: Aug 2024
9 citations
1176 days after retraction
Nanomedicine‐mediated Pulsed Electric Field Ablation Therapy
Xinzhu Yang, Qiong Wu, Ruixue Zhu et al. (4 authors)
Nanomedicine
Published: Jul 2024
1162 days after retraction
Doxorubicin-induced Immunogenic Cell Death Impairs Tumor Progression and Distant Metastasis in a 4T1 Breast Cancer Tumor Model
Camila Magalhães Cardador, Thais Bergmann de de Castro, Raffael Júnio Araújo de Castro et al. (8 authors)
Current Pharmaceutical Design
Published: Jul 2024
2 citations
1159 days after retraction
A β-lapachone-loaded iron-polyphenol nanocomplex enhances chemodynamic therapy through cascade amplification of ROS in tumor
Xueying Shi, Xiaoxuan Zhou, Bing Xiao et al. (11 authors)
Chinese Chemical Letters
Published: Jun 2024
1 citation
1107 days after retraction
Establishment of an immunogenic cell death-related model for prognostic prediction and identification of therapeutic targets in endometrial carcinoma
Zhenran Liu, Yue Huang, Pin Zhang et al. (7 authors)
Aging Open Access
Published: Mar 2024
1 citation
1022 days after retraction
Nano‐therapeutics: The upcoming <scp>nanomedicine</scp> to treat cancer
Hamda Khan, Uzma Shahab, Ahmed Mohajja Alshammari et al. (12 authors)
IUBMB Life
Published: Mar 2024
8 citations
1019 days after retraction
Recent Developments in CaCO3 Nano-Drug Delivery Systems: Advancing Biomedicine in Tumor Diagnosis and Treatment
Chenteng Lin, Muhammad Akhtar, Yingjie Li et al. (5 authors)
Pharmaceutics Open Access
Published: Feb 2024
9 citations
1000 days after retraction
Cancer nanoimmunotherapy in the present scenario
Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Pedro Cruz-Nova et al. (5 authors)
Elsevier eBooks
Published: Jan 2024
955 days after retraction
Lipid-based nanomedicines for cancer immunotherapy
Shadma Wahab
Elsevier eBooks
Published: Jan 2024
955 days after retraction
Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma
Lizhu Chen, Jiexiang Lin, Yaoming Wen et al. (5 authors)
Frontiers in Oncology Open Access
Published: Nov 2023
3 citations
903 days after retraction
An Extensive Research on Immune-modulating MOFbased Nanodrug for Enhanced Photothermal Therapy of Melanoma
Unknown Authors
Unknown Journal Open Access
Published: Nov 2023
1 citation
901 days after retraction
Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3‐dioxygenase inhibitor immunotherapeutic
Parisa Badiee, Michelle F. Maritz, Pouya Dehghankelishadi et al. (5 authors)
Bioengineering & Translational Medicine Open Access
Published: Oct 2023
1 citation
890 days after retraction
It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
Shiya Yao, Yuejun Han, Mengxiang Yang et al. (5 authors)
Frontiers in Immunology Open Access
Published: Oct 2023
4 citations
880 days after retraction
Near‐infrared laser‐activated aggregation‐induced emission nanoparticles boost tumor carbonyl stress and immunotherapy of breast cancer
Pan You, Meng Suo, Qinqin Huang et al. (9 authors)
Aggregate Open Access
Published: Oct 2023
30 citations
865 days after retraction
Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis
Jiaxin Liao, Yuqing Zhang, Min-Ying Huang et al. (11 authors)
Bioorganic Chemistry
Published: Sep 2023
15 citations
839 days after retraction
Potent Zinc(II)-Based Immunogenic Cell Death Inducer Triggered by ROS-Mediated ERS and Mitochondrial Ca<sup>2+</sup> Overload
Lan-Shan Liao, Yin Chen, Cheng Hou et al. (7 authors)
Journal of Medicinal Chemistry
Published: Jul 2023
21 citations
797 days after retraction
Nanotechnology-Aided Advancement in Combating the Cancer Metastasis
Arun Kumar Singh, Rishabha Malviya, Bhupendra G. Prajapati et al. (6 authors)
Pharmaceuticals Open Access
Published: Jun 2023
11 citations
759 days after retraction
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy
Bing Ma, Yingying Ma, Bo Deng et al. (7 authors)
Journal of Nanobiotechnology Open Access
Published: May 2023
19 citations
735 days after retraction
Engineering a facile and versatile nanoplatform to facilitate the delivery of multiple agents for targeted breast cancer chemo-immunotherapy
Amirhossein Bahreyni, Yasir Mohamud, Jingchun Zhang et al. (4 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Apr 2023
11 citations
706 days after retraction
Nucleotides Entrapped in Liposome Nanovesicles as Tools for Therapeutic and Diagnostic Use in Biomedical Applications
Camila Magalhães Cardador, Luís Alexandre Muehlmann, Cíntia Marques Coelho et al. (8 authors)
Pharmaceutics Open Access
Published: Mar 2023
9 citations
656 days after retraction
Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
Lingling Zhu, Xianzhe Yu, Ting Cao et al. (7 authors)
Acta Pharmaceutica Sinica B Open Access
Published: Mar 2023
32 citations
656 days after retraction
Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles
Shulan Han, Yongjie Chi, Zhu Yang et al. (5 authors)
Journal of Functional Biomaterials Open Access
Published: Feb 2023
9 citations
648 days after retraction
Precision Delivery of Dual Immune Inhibitors Loaded Nanomodulator to Reverse Immune Suppression for Combinational Photothermal‐Immunotherapy
Ying Tian, Muhammad Rizwan Younis, Yatong Zhao et al. (8 authors)
Small
Published: Feb 2023
13 citations
637 days after retraction
GM-CSF augmented the photothermal immunotherapeutic outcome of self-driving gold nanoparticles against a mouse CT-26 colon tumor model
Jie Dai, Jianmei Li, Yuqin Zhang et al. (10 authors)
Biomaterials Research Open Access
Published: Feb 2023
18 citations
629 days after retraction
MicroRNAs with Multiple Targets of Immune Checkpoints, as a Potential Sensitizer for Immune Checkpoint Inhibitors in Breast Cancer Treatment
Huiling Zhou, Wentao Jia, Lingeng Lu et al. (4 authors)
Cancers Open Access
Published: Jan 2023
12 citations
618 days after retraction
Bioengineered Bacterial Membrane Vesicles with Multifunctional Nanoparticles as a Versatile Platform for Cancer Immunotherapy
Xin Zheng Liu, Zhi Juan Wen, Yun Meng Li et al. (14 authors)
ACS Applied Materials & Interfaces
Published: Jan 2023
51 citations
600 days after retraction
Engineering a facile and versatile nanoplatform to facilitate the delivery of multiple agents for targeted breast cancer chemo-immunotherapy
Amirhossein Bahreyni, Yasir Mohamud, Jingchun Zhang et al. (4 authors)
Research Square (Research Square) Open Access
Published: Jan 2023
599 days after retraction
Pharmaceutical Nanotechnology
Tao Sun, Chufeng Li, Xuwen Li et al. (8 authors)
Micro/Nano technologies
Published: Jan 2023
4 citations
590 days after retraction
Immunotherapy for Breast Cancer
Kammila Martins Nicolau Costa, Demis Ferreira de Melo, Ingrid Larissa da Silva Soares et al. (5 authors)
Springer eBooks
Published: Jan 2023
2 citations
590 days after retraction
[Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Xiahui Lin, Duo Mao, Renren Bai
PubMed
Published: Dec 2022
2 citations
578 days after retraction
Novel vancomycin free base – Sterosomes for combating diseases caused by Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus infections (S. Aureus and MRSA)
Joshua C. Nwabuife, Daniel Hassan, Amit Pant et al. (8 authors)
Journal of Drug Delivery Science and Technology
Published: Dec 2022
10 citations
575 days after retraction
Challenges and emerging strategies for next generation liposomal based drug delivery: An account of the breast cancer conundrum
Aliesha Moudgil, Rajesh Salve, Virendra Gajbhiye et al. (4 authors)
Chemistry and Physics of Lipids Open Access
Published: Nov 2022
8 citations
539 days after retraction
Hybrid ultrasound-activated nanoparticles based on graphene quantum dots for cancer treatment
Arash Ramedani, Omid Sabzevari, Abdolreza Simchi
International Journal of Pharmaceutics
Published: Nov 2022
21 citations
536 days after retraction
Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
Siyan Liu, Jing Li, Lin Gu et al. (5 authors)
International Journal of Nanomedicine Open Access
Published: Nov 2022
20 citations
529 days after retraction
Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment
Jie Ren, Jiaqi Yang, Na Song et al. (7 authors)
Frontiers in Immunology Open Access
Published: Sep 2022
18 citations
490 days after retraction
Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer
Fenfen Gu, Chuling Hu, Wei Cao et al. (8 authors)
International Journal of Nanomedicine Open Access
Published: Sep 2022
13 citations
468 days after retraction
Plasma and Urine Indoleamine 2,3-Dioxygenase Activity: Promising Biomarkers for Chronic Kidney Disease and Inflammation Status
Hao Hong, Suya Zhou, Haimin Shi et al. (4 authors)
Journal of Inflammation Research Open Access
Published: Sep 2022
5 citations
468 days after retraction
Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy
Qiangwei Liang, Lan Yang, Yifan Li et al. (6 authors)
European Journal of Pharmaceutics and Biopharmaceutics
Published: Jul 2022
18 citations
423 days after retraction
Therapeutic Potential of Ex Vivo Expanded γδ T Cells against Osteosarcoma Cells
Yunmi Ko, Yeon Ho Jeong, Jun Ah Lee
Cells Open Access
Published: Jul 2022
3 citations
416 days after retraction
Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer
Qing Zhao, Xuexin He, Xiyi Qin et al. (12 authors)
Frontiers in Immunology Open Access
Published: Jun 2022
34 citations
398 days after retraction
Evaluating the tumor immune profile based on a three-gene prognostic risk model in HER2 positive breast cancer
Jianqing Lin, Aiyue Zhao, Deqiang Fu
Scientific Reports Open Access
Published: Jun 2022
7 citations
378 days after retraction
PAMAM Dendritic Nanoparticle-Incorporated Hydrogel to Enhance the Immunogenic Cell Death and Immune Response of Immunochemotherapy
Endiries Yibru Hanurry, Yihenew Simegniew Birhan, Haile Fentahun Darge et al. (9 authors)
ACS Biomaterials Science & Engineering
Published: Jun 2022
17 citations
376 days after retraction
Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
Congcong Wang, Ning Li, Yutian Li et al. (11 authors)
Journal of Nanobiotechnology Open Access
Published: May 2022
85 citations
375 days after retraction
A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy
Qian Chen, Shuai Zhou, Yuan Ding et al. (14 authors)
Journal of Controlled Release
Published: Apr 2022
30 citations
337 days after retraction
Quick Stats
Total Citations: 216
Years Since Retraction: 4.5 years
Open Access: Yes
Last Checked: Jul 24, 2025